Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Transplanted Brain Stem Cells Don't Trigger Rejection

By HospiMedica staff writers
Posted on 25 Jul 2003
Scientists have shown for the first time that brain stem cells are invisible to a transplant recipient's immune system and do not trigger the system to reject them, which may eliminate the need for tissue typing and immunosuppressive drugs. More...
The finding was published in the July 2003 issue of Stem Cells.

Certain sites in the body do not mount attacks against foreign tissue because it would be too self-destructive. These sites, known as "immune privileged,” include the brain, the eye, the digestive system, and the reproductive system. To test the suspicion that brain stem cells might be immune privileged, researchers took brain stem cells from mice in which the gene for green protein found in jellyfish had been inserted. These were placed in normal mice under the kidney capsule, the pouch in which the kidney is located, a site that always rejects transplanted tissue without close tissue typing or immunosuppressant drugs. After four weeks, the researchers examined the mice and found that the stem cells had not been rejected in any of the mice and had grown into normal tissue. They concluded that these neural stem cells must be invisible to the immune system.

To determine if the cells possessed the antigens most other tissues have, the researchers took other brain cells that were not stem cells from the green mice and implanted them in the normal mice. These cells were rejected, and when brain stem cells were then implanted in the normal mice, they were also rejected. This showed that brains stem cells do possess antigens but unless the recipient is primed or pre-immunized, the antigens are not visible to the immune system and not rejected.

"These findings are very exciting,” said lead author Michael Young, Ph.D., an assistant professor at Harvard Medical School (Boston, MA, USA). "Though we suspected brain stem cells might be protected in this way, this is the first documented evidence.”




Related Links:
Harvard Med. School

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
12-Channel ECG
CM1200B
New
Tourniquet System
heidi– mein Tourniquet
New
Blood Gas Analyzer
i-Check200
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Health IT

view channel
Photo courtesy of Adobe Stock

Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings

Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.